AdvanSource Biomaterials Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. AdvanSource Biomaterials prevailing Real Value cannot be determined due to lack of data. The current price of AdvanSource Biomaterials is $0.0. Our model approximates the value of AdvanSource Biomaterials from analyzing the firm fundamentals such as Shares Owned By Insiders of 90.02 %, current valuation of 4.83 M, and Return On Equity of -51.46 as well as examining its technical indicators and probability of bankruptcy.
AdvanSource Biomaterials Total Value Analysis
AdvanSource Biomaterials is presently estimated to have valuation of 4.83 M with market capitalization of 3.12 M, debt of 0, and cash on hands of 186 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the AdvanSource Biomaterials fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.83 M | 3.12 M | 0 | 186 K |
AdvanSource Biomaterials Asset Utilization
One of the ways to look at asset utilization of AdvanSource is to check how much profit was generated for every dollar of assets it reports. AdvanSource Biomaterials shows a negative utilization of assets of -495.48 percent, losing $4.95 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of AdvanSource Biomaterials shows how discouraging it operates for each dollar spent on its assets.AdvanSource Biomaterials Ownership Allocation
AdvanSource Biomaterials shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 90.02 percent of AdvanSource Biomaterials outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event.AdvanSource Biomaterials Profitability Analysis
Net Loss for the year was (287 K) with profit before overhead, payroll, taxes, and interest of 2.47 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AdvanSource Biomaterials' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AdvanSource Biomaterials and how it compares across the competition.
AdvanSource Biomaterials Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 944.7 K | |
| Quarterly Earnings Growth Y O Y | -0.564 | |
| Retained Earnings | -33.7 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in AdvanSource Pink Sheet
If you are still planning to invest in AdvanSource Biomaterials check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AdvanSource Biomaterials' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |